PROGRESSIVE INTERSTITIAL LUNG DISEASE IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE

被引：0
|
作者：
Cuomo, G. [1 ]
Di Vico, C. [1 ]
Perretta, D. [1 ]
Iandoli, C. [1 ]
Ciaburri, R. [1 ]
Adamo, P. [1 ]
机构：
[1] Seconda Univ Napoli, Precis Med, Caserta, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
D O I：
10.1136/annrheumdis-2023-eular.4971
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0886
引用
收藏
页码：1657 / 1658
页数：2
相关论文
共 50 条
  • [31] PROTEIN BIOMARKERS AS PREDICTORS OF DISEASE PROGRESSION IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE
    Chiang, Giuliana C. Cerro
    Tahmineh, Romero
    David, Elashoff
    Mitra, Mastali
    Van Eyk, Jennifer
    Boin, Francesco
    Chen, Peter
    Zaman, Tanzira
    [J]. CHEST, 2022, 162 (04) : 1311A - 1311A
  • [32] Characterization of the Pericyte Transcriptome in Systemic Sclerosis-associated Interstitial Lung Disease
    Wilson, C. L.
    Renaud, L.
    Simon, B.
    Feghali-Bostwick, C.
    Schnapp, L. M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [33] Consensus statements for managing systemic sclerosis-associated interstitial lung disease
    Proudman, Susanna
    [J]. LANCET RHEUMATOLOGY, 2020, 2 (02): : E64 - E65
  • [34] Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
    Franck F. Rahaghi
    Vivien M. Hsu
    Robert J. Kaner
    Maureen D. Mayes
    Ivan O. Rosas
    Rajan Saggar
    Virginia D. Steen
    Mary E. Strek
    Elana J. Bernstein
    Nitin Bhatt
    Flavia V. Castelino
    Lorinda Chung
    Robyn T. Domsic
    Kevin R. Flaherty
    Nishant Gupta
    Bashar Kahaleh
    Fernando J. Martinez
    Lee E. Morrow
    Teng Moua
    Nina Patel
    Oksana A. Shlobin
    Brian D. Southern
    Elizabeth R. Volkmann
    Dinesh Khanna
    [J]. Respiratory Research, 24
  • [35] evaluation of esophageal involvement in systemic sclerosis-associated interstitial lung disease
    Abida, Houssem
    Meddeb, Zeineb
    Abdelkefi, Cherifa
    El Ouni, Amira
    Toujani, Sana
    Hamzaoui, Saloua B'chir
    Larbi, Thara
    Bouslama, Kamel
    [J]. ACTA CLINICA BELGICA, 2023, 78 : 19 - 19
  • [36] The hidden costs of living with systemic sclerosis-associated interstitial lung disease
    Parfrey, Helen
    [J]. RESPIROLOGY, 2022, 27 (07) : 486 - 487
  • [37] Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
    Meier, C.
    Freiburghaus, K.
    Bovet, C.
    Schniering, J.
    Allanore, Y.
    Distler, O.
    Nakas, C.
    Maurer, B.
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
  • [38] Management of systemic sclerosis-associated interstitial lung disease in the current era
    Amjadi, Sogol Sara
    Roofeh, David
    Namas, Rajaie
    Khanna, Dinesh
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2020, 23 (02) : 137 - 139
  • [39] Nintedanib: New indication for systemic sclerosis-associated interstitial lung disease
    Kuwana, Masataka
    Azuma, Arata
    [J]. MODERN RHEUMATOLOGY, 2020, 30 (02) : 225 - 231
  • [40] Treatment of systemic sclerosis-associated interstitial lung disease: a work in progress
    Oldham, Justin M.
    [J]. LANCET RESPIRATORY MEDICINE, 2021, 9 (01): : 5 - 7
12345